200 related articles for article (PubMed ID: 36383282)
1. Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis.
Gao S; Zhao Y
Qual Life Res; 2023 Jun; 32(6):1551-1565. PubMed ID: 36383282
[TBL] [Abstract][Full Text] [Related]
2. Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women.
Palacios S; Neyro JL; Fernández de Cabo S; Chaves J; Rejas J
Climacteric; 2014 Feb; 17(1):60-70. PubMed ID: 23710562
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
Al-Sari UA; Tobias J; Clark E
Osteoporos Int; 2016 Oct; 27(10):2891-900. PubMed ID: 27262840
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis.
Hu J; Zheng W; Zhao D; Sun L; Zhou B; Liu J; Wang O; Jiang Y; Xia W; Xing X; Li M
Endocrine; 2021 Nov; 74(2):270-280. PubMed ID: 34165773
[TBL] [Abstract][Full Text] [Related]
5. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials.
Deardorff WJ; Cenzer I; Nguyen B; Lee SJ
JAMA Intern Med; 2022 Jan; 182(1):33-41. PubMed ID: 34807231
[TBL] [Abstract][Full Text] [Related]
6. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life after osteoporotic fractures.
Hallberg I; Rosenqvist AM; Kartous L; Löfman O; Wahlström O; Toss G
Osteoporos Int; 2004 Oct; 15(10):834-41. PubMed ID: 15045468
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures.
Ciubean AD; Ungur RA; Irsay L; Ciortea VM; Borda IM; Onac I; Vesa SC; Buzoianu AD
Clin Interv Aging; 2018; 13():2465-2472. PubMed ID: 30584286
[TBL] [Abstract][Full Text] [Related]
9. The effect of whole-body vibration exercise on postmenopausal women with osteoporosis: A protocol for systematic review and meta-analysis.
Cao S; Wang Z; Li C; Wang Q
Medicine (Baltimore); 2021 May; 100(18):e25606. PubMed ID: 33950937
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.
Hopman WM; Berger C; Joseph L; Morin SN; Towheed T; Anastassiades T; Adachi JD; Hanley DA; Prior JC; Goltzman D;
Osteoporos Int; 2019 Aug; 30(8):1635-1644. PubMed ID: 31069440
[TBL] [Abstract][Full Text] [Related]
11. Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis.
Long G; Liu C; Liang T; Zhang Z; Qin Z; Zhan X
J Orthop Surg Res; 2023 Aug; 18(1):574. PubMed ID: 37543616
[TBL] [Abstract][Full Text] [Related]
12. Denosumab versus Bisphosphonates for Reducing Fractures in Postmenopausal Women with Osteoporosis: A Meta-Analysis.
Thal KA; Nudy M; Moser EM; Foy AJ
J Am Board Fam Med; 2023 Feb; 36(1):175-185. PubMed ID: 36653115
[TBL] [Abstract][Full Text] [Related]
13. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
[TBL] [Abstract][Full Text] [Related]
14. Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures.
Huang CF; Chen JF; Reid IR; Chan WP; Ebeling PR; Langdahl B; Tu ST; Matsumoto T; Chan DC; Chung YS; Chen FP; Lewiecki EM; Tsai KS; Yang RS; Ang SB; Huang KE; Chang YF; Chen CH; Lee JK; Ma HI; Xia W; Mithal A; Kendler DL; Cooper C; Hwang JS; Wu CH
J Formos Med Assoc; 2023; 122 Suppl 1():S14-S20. PubMed ID: 36775679
[TBL] [Abstract][Full Text] [Related]
15. Impact of recent fracture on health-related quality of life in postmenopausal women.
Brenneman SK; Barrett-Connor E; Sajjan S; Markson LE; Siris ES
J Bone Miner Res; 2006 Jun; 21(6):809-16. PubMed ID: 16753011
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
[TBL] [Abstract][Full Text] [Related]
17. Iron accumulation and its impact on osteoporotic fractures in postmenopausal women.
Cai H; Zhang H; He W; Zhang H
J Zhejiang Univ Sci B; 2023 Apr; 24(4):301-311. PubMed ID: 37056206
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS).
Chen CH; Elsalmawy AH; Ish-Shalom S; Lim SJ; AlAli NS; Cunha-Borges JL; Yang H; Casas N; Altan L; Belaya Z; Marin F; Moll T; Gurbuz S; Brnabic A; Pavo I; Florez S
Calcif Tissue Int; 2022 Jan; 110(1):74-86. PubMed ID: 34415388
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
Händel MN; Cardoso I; von Bülow C; Rohde JF; Ussing A; Nielsen SM; Christensen R; Body JJ; Brandi ML; Diez-Perez A; Hadji P; Javaid MK; Lems WF; Nogues X; Roux C; Minisola S; Kurth A; Thomas T; Prieto-Alhambra D; Ferrari SL; Langdahl B; Abrahamsen B
BMJ; 2023 May; 381():e068033. PubMed ID: 37130601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
